|
Massachusetts Boston Drugs & Pharmaceutical Industry News is an EIN News Service for health professionals. Constantly updated news and information about Massachusetts Health.
Latest Massachusetts Boston Drugs & Pharmaceutical Industry News
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 21 Nov 2009 01:11 GMT
... may speed settlements in other similar cases. BOSTON, Nov. 20 /PRNewswire/ -- The United States ... in the long-running Average Wholesale Price (AWP) pharmaceutical litigation against AstraZeneca Pharmaceuticals ( AZN). The ...
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement / Objector's arguments dismissed; ruling may speed settlements in other similar cases. 21 Nov 2009 01:45 GMT
... BOSTON, Nov. 20 /PRNewswire/ -- The United States ... in the long-running Average Wholesale Price (AWP) pharmaceutical litigation against The ruling affirms a settlement ...
- Let's Get this Party Organized 21 Nov 2009 00:52 GMT
... A TEA ROOM USED TO SERVE IN BOSTON WHEN I GREW UP AND MOST OF ... 2010 . I PLAN TO TAKE AN PHARMACY REP CLASS BY THAN AT MIAMI DADE THE ...
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement (PRN) 21 Nov 2009 01:10 GMT
... settlement that awarded consumers who purchased the pharmaceutical giant's prostate cancer drug Zoladex treble damages, ... based in Seattle with offices in Chicago, Boston, Los Angeles, Phoenix and San Francisco. Among ...
- Adverse reactions to the Swine Flu vaccine soar. 21 Nov 2009 09:33 GMT
... similar responses, leaving many Governments and the Pharmaceutical industry seemingly red faced, after buying enough ... coming from a man of power. The Boston Herald reported that the Polish Minister had ...
- Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences 20 Nov 2009 22:11 GMT
... Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two ... and at the 2009 Deutsche Bank Biotech Boston Confab on Tuesday, December 15, 2009 at ...
- PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, November 20, 2009: CNO, NRG, NOC, PFE, ANW and BSX 20 Nov 2009 18:53 GMT
... Marine Petroleum Network Inc. (NYSE: ANW) and Boston Scientific Corporation (NYSE: BSX) -- November 20, ... Inc. (NYSE: PFE) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and ...
- MethylGene Reports Favorable Phase I Data for MGCD265 in Solid Tumors at the AACR-NCI-EORTC Internat 20 Nov 2009 14:50 GMT
... Molecular Targets and Cancer Therapeutics Conference in Boston. MGCD265 is an oral, small molecule multi-targeted ... is to evaluate the maximum-tolerated dose, safety, pharmacodynamics (PD) and pharmacokinetics (PK) of MGCD265 when ...
- Perceptive Informatics Expands Nuclear Imaging Capabilities for Cardiology Trials 20 Nov 2009 11:17 GMT
... Nov 20 00:00:00 GMT 2009 PR Newswire] BOSTON, Nov 17, 2009 /PRNewswire-FirstCall via COMTEX Perceptive ... state-of-the-art technologies into our capabilities to help biopharmaceutical companies further improve the use of medical ...
- Durbin: Lincoln has told Reid 20 Nov 2009 17:59 GMT
... in the pockets of big oil, banks, pharma, insurance, on and on. The right is hoping ... lost as a result. Real nice! Al, Boston No. Not at all. The US should ...
- Alnylam Presents New Pre-clinical Data On ALN-VSP, An RNAi Therapeutic For The Treatment Of Liver Cancer 20 Nov 2009 09:59 GMT
... Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics ... held November 15 - 19, 2009 in Boston, Mass. ALN-VSP is an RNAi therapeutic currently ...
- Exelixis Reports Encouraging Phase 1 Data For The PI3K Inhibitor Xl147 (SAR245408) In Combination With Erlotinib At The AACR-NCI-EORTC Conference 20 Nov 2009 07:35 GMT
... which is being held November 15-19 in Boston. XL147 is being developed with sanofi-aventis. "The ... study for more than 24 weeks. Preliminary pharmacokinetic (PK) analyses indicate that the PK profiles ...
- FDA Extends NDA Review for Exalgo Extended-Release Tablets 20 Nov 2009 12:50 GMT
... - CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced ... of Goodwin Procter LLP, 53 State Street, Boston, MA 02109, and in the case of ...
- FDA Extends NDA Review for Exalgo(TM) Extended-Release Tablets 20 Nov 2009 12:50 GMT
... WIRE)-- CombinatoRx, Incorporated (NASDAQ: ) and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced ... of Goodwin Procter LLP, 53 State Street, Boston, MA 02109, and in the case of ...
- FDA Extends NDA Review for Exalgo'¢ Extended-Release Tablets 20 Nov 2009 12:50 GMT
... Tablets )--CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced ... of Goodwin Procter LLP, 53 State Street, Boston, MA 02109, and in the case of ...
Powered by 
Massachusetts Health News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
>
Boston Drugs & Pharmaceutical Industry
bbc.co.uk:
ap.org:
healthday.com:
msnbc.msn.com: